Proteomics

Dataset Information

0

Gmppa defects result in a treatable syndromic myopathy with α-Dystroglycan hyperglycosylation


ABSTRACT: Mutations in GDP-mannose-pyrophosphorylase-A (Gmppa) are associated with a syndromic disorder with deficits such as muscular hypotonia and weakness, achalasia, alacrima, and mental retardation (AAMR-syndrome). Gmppa is catalytically inactive, while its homolog Gmppb converts GTP and mannose-1-phosphate into GDP-mannose, which is a substrate for protein glycosylation. Suggesting that Gmppa is an allosteric inhibitor of Gmppb, Gmppa and Gmppb interact and disruption of Gmppa in mice increases GDP-mannose tissue levels. KO mice develop a myopathic disorder characterized by hyperglycosylation of the sarcolemma-associated protein α-Dystroglycan (α-Dg), while the overall abundance of α-Dg is reduced. This reduction is also observed in skeletal muscle biopsies of AAMR patients and in myoblasts upon knockdown of Gmppa. The knockdown does not impair myoblast differentiation but compromises myotube maintenance. Dietary mannose depletion prevents α-Dg hyperglycosylation and the deterioration of motor functions in mice. Thus our data suggest that the disorder is at least in part preventable.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Leg Muscle

SUBMITTER: Alessandro Ori  

LAB HEAD: Alessandro Ori

PROVIDER: PXD014260 | Pride | 2021-04-15

REPOSITORIES: Pride

Similar Datasets

2023-03-11 | PXD037129 | Pride
2010-05-08 | E-GEOD-15616 | biostudies-arrayexpress
2023-02-27 | E-MTAB-11750 | biostudies-arrayexpress
2024-03-11 | GSE236887 | GEO
2020-03-11 | PXD012404 | Pride
2020-03-11 | PXD012402 | Pride
2020-03-11 | PXD012401 | Pride
2020-03-11 | PXD012403 | Pride
2020-03-11 | PXD012400 | Pride
2019-06-06 | E-MTAB-7262 | biostudies-arrayexpress